Related Experiment Video
Updated: May 12, 2026
13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Moving towards individualized medicine with pharmacogenomics
William E Evans1, Mary V Relling
1Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. william.evans@stjude.org
Nature
|May 28, 2004
Summary
Genetic variations significantly impact how individuals respond to medications, leading to unpredictable effects. Understanding these genetic factors is key to developing personalized medicine and optimizing drug therapies for better patient outcomes.
Area of Science:
- Pharmacogenomics
- Molecular Medicine
- Genetics
Background:
- Individual responses to drug therapy vary significantly.
- Genetic differences influencing drug-target proteins are a major cause of this variability.
- Early research focused on single-gene traits, but complex multi-gene interactions are crucial for a complete understanding.
Purpose of the Study:
- To highlight the role of genetic variations in determining drug response.
- To emphasize the need to investigate multi-gene determinants of pharmacogenomics.
- To underscore the potential of genomics in personalizing drug therapy.
Main Methods:
- Review of existing literature on pharmacogenomics and drug response.
- Analysis of the impact of DNA variations on protein function and drug efficacy.
- Discussion of the transition from single-gene to multi-gene approaches in genetic research.
Main Results:
- Genetic variations significantly contribute to inter-individual differences in drug response.
- Elucidating multi-gene determinants presents a significant challenge but is essential for progress.
- Genomic insights are paving the way for molecular diagnostic tools.
Conclusions:
- Personalized medicine, guided by pharmacogenomics, can optimize drug therapy.
- Understanding genetic influences on drug response is critical for improving patient outcomes.
- The integration of genomics and medicine promises advanced molecular diagnostics for tailored treatments.
More Related Videos
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...